Edition:
United Kingdom

Jounce Therapeutics Inc (JNCE.OQ)

JNCE.OQ on NASDAQ Stock Exchange Global Select Market

6.74USD
18 Sep 2018
Change (% chg)

-- (--)
Prev Close
$6.74
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
162,829
52-wk High
$29.02
52-wk Low
$6.30

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 19.38 -0.144
Mar '18 11.19 -0.402
FY 2017 Dec '17 12.99 -0.290
Sep '17 18.08 -0.127
Jun '17 20.29 -0.105
Mar '17 20.29 -0.017
FY 2016 Dec '16 20.29 0.076
Sep '16 16.91 0.004
Jun '16 0.00 -0.238
Mar '16 0.00 -6.811
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 6 13.12 15.50 11.00 74.10
Quarter Ending Dec-18 6 12.61 15.50 10.68 104.10
Year Ending Dec-18 6 56.46 61.57 53.00 119.14
Year Ending Dec-19 6 68.55 86.25 43.00 68.75
Earnings (per share)
Quarter Ending Sep-18 6 -0.34 -0.27 -0.42 1.58
Quarter Ending Dec-18 6 -0.37 -0.27 -0.48 2.50
Year Ending Dec-18 6 -1.26 -1.08 -1.44 -0.19
Year Ending Dec-19 6 -1.22 -0.25 -2.33 -2.62
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 7,903.67 85.68 32.76
P/E High - Last 5 Yrs. -- 300.71 45.44
P/E Low - Last 5 Yrs. -- 92.08 24.26
Beta -- 0.93 0.89
Price to Sales (TTM) 7.13 114.98 5.75
Price to Book (MRQ) 3.12 15.51 5.00
Price to Tangible Book (MRQ) 3.12 14.52 6.57
Price to Cash Flow (TTM) 137.44 72.88 23.29
% Owned Institutions 86.67 14.70 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.51
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.72 5.22
Payout Ratio(TTM) 0.00 16.50 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 411.55 8.01
Sales (TTM) vs TTM 1 Yr. Ago -- 80.36 5.64
Sales - 5 Yr. Growth Rate -- 32.26 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago 55.85 29.15 20.61
EPS (TTM) vs TTM 1 Yr. Ago 100.03 -- --
EPS - 5 Yr. Growth Rate -- 39.84 10.66
Capital Spending - 5 Yr. Growth Rate -- 40.42 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.91 2.22
Current Ratio (MRQ) 3.54 5.46 3.03
LT Debt to Equity (MRQ) 0.00 35.26 12.51
Total Debt to Equity (MRQ) 0.00 37.08 16.85
Interest Coverage (TTM) -- -102.35 32.65

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 39.18 54.37
Gross Margin - 5 Yr. Avg. -- 50.58 52.17
EBITD Margin (TTM) 11.77 -- --
EBITD - 5 Yr. Avg -- -600.64 10.68
Operating Margin (TTM) 7.10 -759.75 4.32
Operating Margin - 5 Yr. Avg. -- -621.68 6.11
Pre-Tax Margin (TTM) 9.83 -733.60 5.18
Pre-Tax Margin - 5 Yr. Avg. -- -627.38 6.51
Net Profit Margin (TTM) 8.41 -734.97 1.48
Net Profit Margin - 5 Yr. Avg. -- -630.42 2.78
Effective Tax Rate (TTM) 14.44 23.33 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.66 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) 915,000 23,230,020 860,375,045
Net Income/Employee (TTM) 76,953 3,144,156 101,207,177
Receivable Turnover (TTM) -- 20.89 5.87
Inventory Turnover (TTM) -- 2.46 3.41
Asset Turnover (TTM) 0.43 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 3.58 -0.16 11.13
Return on Assets - 5 Yr. Avg. -- 3.51 12.40
Return on Investment (TTM) 4.65 1.78 14.61
Return on Investment - 5 Yr. Avg. -- 2.56 16.13
Return on Equity (TTM) 0.82 3.29 16.33
Return on Equity - 5 Yr. Avg. -- 3.43 17.39
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 36.71 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Jounce Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 13.73 9.81 75 53
13 Week 20.24 14.38 74 66
26 Week -23.39 -29.21 27 80
52 Week -- -- -- 50
YTD -- -- -- 61
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 82.80%
# of Holders: 119
Total Shares Held: 27,014,871
3 Mo. Net Change: -2,506,621
# New Positions: 21
# Closed Positions: 39
# Increased Positions: 64
# Reduced Positions: 63
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.